Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Longitudinal study of alexithymia and multiple sclerosis.
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany.
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
Do cortical lesions help us to distinguish MS from NMO?
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Biomarkers of treatment response in multiple sclerosis.
Can the ABILHAND handle manual ability in MS?
The therapeutic value of yoga in neurological disorders.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Overall Memory Impairment Identification with Mathematical Modeling of the CVLT-II Learning Curve in Multiple Sclerosis.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.

Pages